29 related articles for article (PubMed ID: 8797580)
1. Sarcoma and the 100,000 Genomes Project: our experience and changes to practice.
Prendergast SC; Strobl AC; Cross W; Pillay N; Strauss SJ; Ye H; Lindsay D; Tirabosco R; Chalker J; Mahamdallie SS; Sosinsky A; ; ; Flanagan AM; Amary F
J Pathol Clin Res; 2020 Oct; 6(4):297-307. PubMed ID: 32573957
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and therapeutic value of the Hippo pathway, RABL6A, and p53-MDM2 axes in sarcomas.
Desai C; Thomason J; Kohlmeyer JL; Reisetter AC; Ahirwar P; Jahanseir K; Leidinger M; Ofori-Amanfo G; Fritchie K; Velu SE; Breheny P; Quelle DE; Tanas MR
Oncotarget; 2021 Apr; 12(8):740-755. PubMed ID: 33889298
[TBL] [Abstract][Full Text] [Related]
3.
Ignatius MS; Hayes MN; Moore FE; Tang Q; Garcia SP; Blackburn PR; Baxi K; Wang L; Jin A; Ramakrishnan A; Reeder S; Chen Y; Nielsen GP; Chen EY; Hasserjian RP; Tirode F; Ekker SC; Langenau DM
Elife; 2018 Sep; 7():. PubMed ID: 30192230
[TBL] [Abstract][Full Text] [Related]
4. Detection of P53 mutations in different cancer types is improved by cDNA sequencing.
Piaskowski S; Zawlik I; Szybka M; Kulczycka-Wojdala D; Stoczynska-Fidelus E; Bienkowski M; Robak T; Kusinska R; Jesionek-Kupnicka D; Kordek R; Rieske P; Liberski PP
Oncol Lett; 2010 Jul; 1(4):717-721. PubMed ID: 22966368
[TBL] [Abstract][Full Text] [Related]
5. Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?
Pennacchioli E; Tosti G; Barberis M; De Pas TM; Verrecchia F; Menicanti C; Testori A; Mazzarol G
Clin Exp Metastasis; 2012 Oct; 29(7):757-73. PubMed ID: 22699363
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal dedifferentiated liposarcoma: a case report.
Karaman A; Kabalar ME; Ozcan O; Koca T; Binici DN
World J Gastroenterol; 2008 Oct; 14(38):5927-9. PubMed ID: 18855997
[TBL] [Abstract][Full Text] [Related]
7. p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas.
Mousses S; Gokgoz N; Wunder JS; Ozcelik H; Bull S; Bell RS; Andrulis IL
Br J Cancer; 2001 Jun; 84(12):1635-9. PubMed ID: 11401317
[TBL] [Abstract][Full Text] [Related]
8. The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas.
Maula S; Huuhtanen RL; Blomqvist CP; Wiklund TA; Laurila P; Ristamäki R
Br J Cancer; 2001 Jan; 84(2):244-52. PubMed ID: 11161384
[TBL] [Abstract][Full Text] [Related]
9. Soft tissue sarcomas and p53 mutations.
Taubert H; Meye A; Würl P
Mol Med; 1998 Jun; 4(6):365-72. PubMed ID: 10780879
[No Abstract] [Full Text] [Related]
10. Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours.
Nawa G; Miyoshi Y; Yoshikawa H; Ochi T; Nakamura Y
Br J Cancer; 1999 Jun; 80(8):1185-9. PubMed ID: 10376970
[TBL] [Abstract][Full Text] [Related]
11. Frequent p53 gene mutations in soft tissue sarcomas arising in burn scar.
Nakanishi H; Tomita Y; Yoshikawa H; Sato N; Ochi T; Aozasa K
Jpn J Cancer Res; 1999 Mar; 90(3):276-9. PubMed ID: 10359041
[TBL] [Abstract][Full Text] [Related]
12. p53 status in radiation-induced soft-tissue sarcomas.
Taubert H; Meye A; Bache M; Hinze R; Holzhausen HJ; Schmidt H; Rath FW; Dunst J; Würl P
Strahlenther Onkol; 1998 Aug; 174(8):427-30. PubMed ID: 9739384
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies.
Würl P; Taubert H; Meye A; Berger D; Lautenschläger C; Holzhausen HJ; Schmidt H; Kalthoff H; Rath FW; Dralle H
J Cancer Res Clin Oncol; 1997; 123(9):502-8. PubMed ID: 9341900
[TBL] [Abstract][Full Text] [Related]
14. Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients.
Taubert H; Meye A; Würl P
Cancer Res; 1996 Sep; 56(18):4134-6. PubMed ID: 8797580
[TBL] [Abstract][Full Text] [Related]
15. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
16. [Frequency, distribution and prognostic relevance of p53 mutations in soft tissue sarcomas].
Taubert H; Würl P; Meye A; Bache M; Kroll J; Lautenschläger C; Thamm B; Holzhausen HJ; Hinze R; Schmidt H; Berger D; Rath FW
Verh Dtsch Ges Pathol; 1998; 82():340-4. PubMed ID: 10095457
[TBL] [Abstract][Full Text] [Related]
17. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
[TBL] [Abstract][Full Text] [Related]
18. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
19. Sarcoma-The standard-bearer in cancer discovery.
Potter JW; Jones KB; Barrott JJ
Crit Rev Oncol Hematol; 2018 Jun; 126():1-5. PubMed ID: 29759550
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
